icon bookmark-bicon bookmarkicon cameraicon checkicon chevron downicon chevron lefticon chevron righticon chevron upicon closeicon v-compressicon downloadicon editicon v-expandicon fbicon fileicon filtericon flag ruicon full chevron downicon full chevron lefticon full chevron righticon full chevron upicon gpicon insicon mailicon moveicon-musicicon mutedicon nomutedicon okicon v-pauseicon v-playicon searchicon shareicon sign inicon sign upicon stepbackicon stepforicon swipe downicon tagicon tagsicon tgicon trashicon twicon vkicon yticon wticon fm

On the road to herd immunity? Nearly 3 million people in England have coronavirus antibodies

On the road to herd immunity? Nearly 3 million people in England have coronavirus antibodies
Health officials announced a positive development in the UK’s battle against Covid-19 on Friday, as new statistics revealed that almost three million people in England have developed coronavirus antibodies.

The fresh analysis by the Office for National Statistics (ONS) found that, if everyone in the country was tested, around one in every 17 people in England would have antibodies for the virus that has claimed over 40,000 lives in the UK, according to official figures.

The latest household infection survey suggests that about 2.7 million people in England have developed some degree of immunity to Covid-19. This represents around 6 percent of the population.

Also on rt.com Liverpool cop FIGHTS, pepper-sprays, & handcuffs maskless commuter with alleged ‘health condition,’ triggering online wrath

The data also found that an average of 2,000 people per day were estimated to be newly infected with Covid-19 between August 19 and 25 – the latest date for which there are figures. This is broadly in line with previous weeks’ stats.

The fresh ONS data comes just one day after a new study found that antibody testing may be underestimating the number of people previously infected by the virus. The research, published in the British Medical Journal, said that large-scale surveys may not capture all those who have developed an immune response to the disease.

Like this story? Share it with a friend!

Podcasts